REG - Abbott Laboratories - Statement of changes in Director/PDMR Shareholding <Origin Href="QuoteRef">ABT.N</Origin>
RNS Number : 4568FAbbott Laboratories27 July 2016
Notification to RNS
Company: Abbott Laboratories
Headline: Abbott Laboratories Files Forms 4
Abbott Laboratories (the "Company")
27 July 2016
Abbott Laboratories Files Forms 4
The Company informs its shareholders that on 27 July, 2016, in accordance with Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, several Forms 4 (the report on Form 4 being a statement of changes in the beneficial ownership of its officers, directors and 10% owners) ("Form 4") were filed with the U.S. Securities and Exchange Commission ("SEC"). The Forms 4 can be found on the SEC website at http://www.sec.gov.
A copy of the Forms 4 have been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial: Scott Leinenweber, +1-224-668-0791, Michael Comilla, +1-224-668-1872, or Jeffrey Byrne, +1-224-668-8808, or Media: Scott Stoffel, +1-224-668-5201, Darcy Ross, +1-224-667-3655, or Elissa Maurer, +1-224-668-3309.
This information is provided by RNSThe company news service from the London Stock ExchangeENDDSHEAEXXADKKEAF
Recent news on Abbott LaboratoriesSee all news
News News News News News